Core Insights - Beckman Coulter Life Sciences has achieved a significant milestone in localizing its production in China with the launch of the Optima XPN-100 ultracentrifuge, marking the establishment of complete local production and quality validation capabilities for ultracentrifuges in the country [1][3] Group 1: Production and Quality Management - The local production of the Optima XPN-100 signifies the formation of an engineering and quality management system that supports high-end centrifuge manufacturing in China, laying a sustainable foundation for future localization of high-end instruments [3] - The Suzhou factory has developed a comprehensive process system that includes quality management, supply chain management, environmental testing, assembly processes, and performance validation, ensuring stable supply for the production of ultracentrifuges [5][8] Group 2: Product Features and Applications - The Optima XPN-100 is a flagship ultracentrifuge with a maximum speed of 100,000 rpm and a maximum centrifugal force of 802,000 x g, featuring revolutionary innovations such as intelligent temperature control and dynamic inertia detection, providing efficient and high-purity separation for samples like nucleic acids, proteins, and viral particles [4][11] - This ultracentrifuge plays an irreplaceable role in significant scientific breakthroughs, including the Human Genome Project, mRNA vaccine development, CAR-T cell therapy, and AAV gene vector purification [7] Group 3: Commitment to Local Market - The local production of the Optima XPN-100 is a fulfillment of the company's long-term commitment to Chinese customers, significantly shortening delivery times and enhancing installation, debugging, and after-sales service response speeds [9] - The company plans to produce more models of high-speed centrifuges and cell counters at the Suzhou factory, continuously enhancing local R&D, manufacturing, and service capabilities to support the development of life sciences research in China [9]

摘要 ： 近日，首批由苏州工厂本地量产的Optima XPN-100超速离心机正式下线，标志着贝克曼库尔特生命科学在中国已具备超速离心机的完整本土化生产与 质量验证能力。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 1 2月1 2日，贝克曼库尔特生命科学在中国的本土化布局迎来又一重要进展。 首批由苏州工厂本地量产的Optima XPN- 1 0 0超速离心机正式下 线 ， 标志着公司在中国已具备超速离心机的完整本土化生产与质量验证能力。 这一节点不仅是生产环节的落地，更意味着贝克曼库尔特生命科学在中国正式形成支撑高端离心设备量产的工程化与质量管理体系，为未来更 广范围的高端仪器本地化奠定了可持续的能力基础。 点击"阅读原文"了解更多 | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ， 版 权 归 原 作 者 所 有 ， 观 点 代 表 作 者 本 人 ， 不 代 表 本 号 立 场 | 转 载 ： 须 本 号 授 权 ， 请 联 系 主 编 | 来 源 ： 仪 器 信 息 网 | 作 者 ： Ev | 责 编 ： 安 安 | 视 ...